Clinical importance of pharmacogenetic polymorphisms affecting drug metabolism [electronic resource] : Part II. Internal medicine / Julia Stingl (Kirchheiner).
Material type:
FilmSeries: Henry Stewart talksBiomedical & life sciences collection. Drug metabolizing enzymes : fundamentals, study methods, recent advances and clinical significance: Publisher: London : Henry Stewart Talks, 2016Description: 1 online resource (1 streaming video file (39 min.) : color, sound)Other title: Internal medicineSubject(s): Cytochrome P-450 | Drugs -- Metabolism | Pharmacogenetics | Cytochrome P-450 Enzyme System | Enzymes -- pharmacokinetics | Inactivation, Metabolic | Pharmaceutical Preparations -- metabolism | Pharmacogenetics -- methods | Polymorphism, Genetic | Risk AssessmentOnline resources: Click here to access online | Series Animated audio-visual presentation with synchronized narration.
Title from title frames.
Updated version of a talk first published in 2007.
Contents: Genetic variability in pharmacokinetics -- Polymorphic drug-metabolizing enzymes (Cytochrome P450) -- Implementation of pharmacogenetics in drug therapy -- Risks and benefits of being a poor metabolizer -- Limitations of genetics-based dose adjustments -- Future clinical study directions in pharmacogenetics.
Access restricted to subscribers.
Mode of access: World Wide Web.